(OXY) Occidental Petroleum - Ratings and Ratios
Oil, Gas, Chemicals, Vinyls, Midstream
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.38% |
| Yield on Cost 5y | 5.89% |
| Yield CAGR 5y | 1.78% |
| Payout Consistency | 90.6% |
| Payout Ratio | 35.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 27.4% |
| Value at Risk 5%th | 44.0% |
| Relative Tail Risk | -2.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.36 |
| Alpha | -29.23 |
| CAGR/Max DD | -0.24 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.424 |
| Beta | 0.941 |
| Beta Downside | 1.415 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.94% |
| Mean DD | 19.28% |
| Median DD | 14.56% |
Description: OXY Occidental Petroleum December 03, 2025
Occidental Petroleum (OXY) is an integrated energy company that acquires, explores, and develops oil and gas assets in the U.S. and abroad, while also operating a chemicals business and a midstream & marketing franchise. Its three operating segments are (1) Oil & Gas – producing crude, condensate, natural-gas liquids (NGLs) and dry gas; (2) Chemical – manufacturing basic chemicals (e.g., chlorine, caustic soda) and vinyl products such as PVC; and (3) Midstream & Marketing – handling the gathering, processing, transport, storage, and sale of hydrocarbons, CO₂ and power.
Key quantitative signals as of Q2 2024: production averaged 1.2 MMbbl eq per day, with a ~30 % share coming from the Permian basin, while the chemical segment posted an adjusted EBITDA margin of ≈ 15 % driven by higher PVC demand. The company’s balance sheet shows a net debt-to-EBITDA ratio of ≈ 2.5×, reflecting a disciplined deleveraging plan that targets $3 billion of free cash flow in 2024. A material sector driver is the volatility of crude oil prices, which directly impacts OXY’s upstream earnings, while the long-term growth of petrochemical demand in North America underpins the chemical segment’s outlook.
For a deeper dive into OXY’s valuation metrics, the ValueRay platform offers a concise, data-driven snapshot.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (2.07b TTM) > 0 and > 6% of Revenue (6% = 1.61b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -2.27% (prev 0.05%; Δ -2.32pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 11.25b > Net Income 2.07b (YES >=105%, WARN >=100%) |
| Net Debt (20.72b) to EBITDA (12.15b) ratio: 1.71 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.94 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.00b) change vs 12m ago 2.81% (target <= -2.0% for YES) |
| Gross Margin 33.57% (prev 35.27%; Δ -1.70pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 31.63% (prev 32.07%; Δ -0.43pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.58 (EBITDA TTM 12.15b / Interest Expense TTM 1.19b) >= 6 (WARN >= 3) |
Altman Z'' 1.67
| (A) -0.01 = (Total Current Assets 8.81b - Total Current Liabilities 9.42b) / Total Assets 83.47b |
| (B) 0.27 = Retained Earnings (Balance) 22.20b / Total Assets 83.47b |
| (C) 0.05 = EBIT TTM 4.26b / Avg Total Assets 84.64b |
| (D) 0.48 = Book Value of Equity 22.64b / Total Liabilities 46.71b |
| Total Rating: 1.67 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.87
| 1. Piotroski 4.50pt |
| 2. FCF Yield 6.32% |
| 3. FCF Margin 14.19% |
| 4. Debt/Equity 0.63 |
| 5. Debt/Ebitda 1.71 |
| 6. ROIC - WACC (= -0.24)% |
| 7. RoE 5.87% |
| 8. Rev. Trend -72.47% |
| 9. EPS Trend -79.46% |
What is the price of OXY shares?
Over the past week, the price has changed by +0.35%, over one month by -4.00%, over three months by -15.50% and over the past year by -14.78%.
Is OXY a buy, sell or hold?
- Strong Buy: 4
- Buy: 4
- Hold: 17
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the OXY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.9 | 23.5% |
| Analysts Target Price | 49.9 | 23.5% |
| ValueRay Target Price | 36.8 | -9% |
OXY Fundamental Data Overview December 26, 2025
P/E Trailing = 29.4118
P/E Forward = 20.202
P/S = 1.4815
P/B = 1.4123
P/EG = 2.3851
Beta = 0.392
Revenue TTM = 26.77b USD
EBIT TTM = 4.26b USD
EBITDA TTM = 12.15b USD
Long Term Debt = 20.21b USD (from longTermDebt, last quarter)
Short Term Debt = 2.03b USD (from shortTermDebt, last quarter)
Debt = 22.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.72b USD (from netDebt column, last quarter)
Enterprise Value = 60.13b USD (39.41b + Debt 22.88b - CCE 2.16b)
Interest Coverage Ratio = 3.58 (Ebit TTM 4.26b / Interest Expense TTM 1.19b)
FCF Yield = 6.32% (FCF TTM 3.80b / Enterprise Value 60.13b)
FCF Margin = 14.19% (FCF TTM 3.80b / Revenue TTM 26.77b)
Net Margin = 7.72% (Net Income TTM 2.07b / Revenue TTM 26.77b)
Gross Margin = 33.57% ((Revenue TTM 26.77b - Cost of Revenue TTM 17.79b) / Revenue TTM)
Gross Margin QoQ = 32.62% (prev 30.19%)
Tobins Q-Ratio = 0.72 (Enterprise Value 60.13b / Total Assets 83.47b)
Interest Expense / Debt = 1.18% (Interest Expense 270.0m / Debt 22.88b)
Taxrate = 27.79% (324.0m / 1.17b)
NOPAT = 3.07b (EBIT 4.26b * (1 - 27.79%))
Current Ratio = 0.94 (Total Current Assets 8.81b / Total Current Liabilities 9.42b)
Debt / Equity = 0.63 (Debt 22.88b / totalStockholderEquity, last quarter 36.26b)
Debt / EBITDA = 1.71 (Net Debt 20.72b / EBITDA 12.15b)
Debt / FCF = 5.45 (Net Debt 20.72b / FCF TTM 3.80b)
Total Stockholder Equity = 35.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.48% (Net Income 2.07b / Total Assets 83.47b)
RoE = 5.87% (Net Income TTM 2.07b / Total Stockholder Equity 35.21b)
RoCE = 7.68% (EBIT 4.26b / Capital Employed (Equity 35.21b + L.T.Debt 20.21b))
RoIC = 6.07% (NOPAT 3.07b / Invested Capital 50.62b)
WACC = 6.31% (E(39.41b)/V(62.28b) * Re(9.48%) + D(22.88b)/V(62.28b) * Rd(1.18%) * (1-Tc(0.28)))
Discount Rate = 9.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.75%
[DCF Debug] Terminal Value 68.56% ; FCFE base≈4.14b ; Y1≈3.26b ; Y5≈2.14b
Fair Price DCF = 32.08 (DCF Value 31.61b / Shares Outstanding 985.2m; 5y FCF grow -25.35% → 3.0% )
EPS Correlation: -79.46 | EPS CAGR: -20.03% | SUE: 1.30 | # QB: 1
Revenue Correlation: -72.47 | Revenue CAGR: -4.24% | SUE: -0.55 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.42 | Chg30d=-0.051 | Revisions Net=-1 | Analysts=9
EPS next Year (2026-12-31): EPS=1.57 | Chg30d=-0.308 | Revisions Net=-5 | Growth EPS=-30.1% | Growth Revenue=-18.2%
Additional Sources for OXY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle